Evidence map›Paper›PMID 27016404›Full record

ArticleBrain : a journal of neurology2016

Motor neuron degeneration in spastic paraplegia 11 mimics amyotrophic lateral sclerosis lesions.

Paola S Denora, Katrien Smets, Federica Zolfanelli, Chantal Ceuterick-de Groote, Carlo Casali, Tine Deconinck, Anne Sieben, Michael Gonzales, Stephan Zuchner, Frédéric Darios and 8 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Brain : a journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Hereditary spastic paraplegia with thin corpus callosum and SPG11 mutation: A neuropathological evaluation.Neuropathology : official journal of the Japanese Society of Neuropathology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The endolysosomal pathway and ALS/FTD.Trends in neurosciences · 2023
    Review
  13. Article
  14. Syringomyelia: A New Phenotype ofBrain & NeuroRehabilitation · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A case of spastic paraplegia type 11 mimicking a GM2-gangliosidosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 4 countries.

Paola S Denora1 Ecole Pratique des Hautes Etudes, EPHE, PSL université, laboratoire de neurogénétique, F-75013, Paris, France 2 Inserm, U1127, F-75013, Paris, France 3 CNRS, UMR7225, F-75013, Paris, France 4 Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière - ICM, Pitié-Salpêtrière Hospital, F-75013, Paris, France 5 Department of Genetics and Rare Diseases, IRCCS Bambino Gesu' Children Hospital, Rome, Italy.
Katrien Smets6 Neurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Belgium 7 Laboratories of Neurogenetics, Institute Born-Bunge, University of Antwerp, Belgium 8 Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.
Federica Zolfanelli9 Pathology Department, San Giovanni di Dio Hospital, Florence, Italy.
Chantal Ceuterick-de Groote10 Institute Born-Bunge, University of Antwerp, Belgium.
Carlo Casali11 Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University, Polo Pontino Rome, Italy.
Tine Deconinck6 Neurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Belgium 7 Laboratories of Neurogenetics, Institute Born-Bunge, University of Antwerp, Belgium.
Anne Sieben10 Institute Born-Bunge, University of Antwerp, Belgium 12 Department of Neurology, University Hospital Gent, Belgium.
Michael Gonzales13 Department of Human Genetics and Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Stephan Zuchner13 Department of Human Genetics and Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Frédéric Darios2 Inserm, U1127, F-75013, Paris, France 3 CNRS, UMR7225, F-75013, Paris, France 4 Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière - ICM, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Dirk Peeters14 Department of Neurology, AZ Groeninge, Kortrijk, Belgium.
Alexis Brice2 Inserm, U1127, F-75013, Paris, France 3 CNRS, UMR7225, F-75013, Paris, France 4 Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière - ICM, Pitié-Salpêtrière Hospital, F-75013, Paris, France 15 APHP, Département de Génétique, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Alessandro Malandrini16 Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Peter De Jonghe6 Neurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Belgium 7 Laboratories of Neurogenetics, Institute Born-Bunge, University of Antwerp, Belgium 8 Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.
Filippo M Santorelli17 Molecular Medicine Laboratory, IRCCS Stella Maris Foundation, Calambrone, Pisa, Italy.
Giovanni Stevanin1 Ecole Pratique des Hautes Etudes, EPHE, PSL université, laboratoire de neurogénétique, F-75013, Paris, France 2 Inserm, U1127, F-75013, Paris, France 3 CNRS, UMR7225, F-75013, Paris, France 4 Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière - ICM, Pitié-Salpêtrière Hospital, F-75013, Paris, France 15 APHP, Département de Génétique, Pitié-Salpêtrière Hospital, F-75013, Paris, France giovanni.stevanin@upmc.fr jean-jacques.martin@uantwerpen.be.
Jean-Jacques Martin10 Institute Born-Bunge, University of Antwerp, Belgium giovanni.stevanin@upmc.fr jean-jacques.martin@uantwerpen.be.
Khalid H El Hachimi1 Ecole Pratique des Hautes Etudes, EPHE, PSL université, laboratoire de neurogénétique, F-75013, Paris, France 2 Inserm, U1127, F-75013, Paris, France 3 CNRS, UMR7225, F-75013, Paris, France 4 Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière - ICM, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Sorbonne Université · FRUniversity of Antwerp · BEUniversity of Miami · USVIB-UAntwerp Center for Molecular Neurology · BEAntwerp University Hospital · BEAZ Groeninge · BEÉcole Pratique des Hautes Études · FRFondazione Stella Maris · ITGhent University Hospital · BEInserm · FRNuovo Ospedale San Giovanni di Dio · ITUniversity of Siena · IT

Funding

European Research Council 311149
6 · The paper itself

Abstract

The most common form of autosomal recessive hereditary spastic paraplegia is caused by mutations in the SPG11/KIAA1840 gene on chromosome 15q. The nature of the vast majority of SPG11 mutations found to date suggests a loss-of-function mechanism of the encoded protein, spatacsin. The SPG11 phenotype is, in most cases, characterized by a progressive spasticity with neuropathy, cognitive impairment and a thin corpus callosum on brain MRI. Full neuropathological characterization has not been reported to date despite the description of >100 SPG11 mutations. We describe here the clinical and pathological features observed in two unrelated females, members of genetically ascertained SPG11 families originating from Belgium and Italy, respectively. We confirm the presence of lesions of motor tracts in medulla oblongata and spinal cord associated with other lesions of the central nervous system. Interestingly, we report for the first time pathological hallmarks of SPG11 in neurons that include intracytoplasmic granular lysosome-like structures mainly in supratentorial areas, and others in subtentorial areas that are partially reminiscent of those observed in amyotrophic lateral sclerosis, such as ubiquitin and p62 aggregates, except that they are never labelled with anti-TDP-43 or anti-cystatin C. The neuropathological overlap with amyotrophic lateral sclerosis, associated with some shared clinical manifestations, opens up new fields of investigation in the physiopathological continuum of motor neuron degeneration.

Indexed as

AdultAmyotrophic Lateral SclerosisBrainFemaleGanglia, SpinalHumansLysosomesMaleMedulla OblongataMiddle AgedMotor NeuronsMutationNerve DegenerationProteinsSpastic Paraplegia, HereditarySpinal CordProteinsSPG11 protein, humanamyotrophic lateral sclerosislipofuscinlysosomespastic paraplegia 11spatacsin

Identifiers

PMID27016404
PMCPMC5839621
OpenAlexW2309939548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.